Additionally, our data revealed an increase in the expression of ABCC3 in chemotherapy-treated breast cancer patient samples (Fig 3B, S4 and S6 Tables) compared to chemo-naive samples, suggesting a possible role for ABCC3 in treatment-induced drug resistance in breast cancers. This evidence concerns the gene ABCC3 and breast carcinoma.